Eric H. Radany

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Histone deacetylase inhibitors (HDIs) have shown promise as candidate radiosensitizer for many types of cancers. However, the mechanisms of action are not well understood, and whether they could have clinical impact on radiotherapy for leukemia is unclear. In this study, we demonstrate that suberoylanilide hydroxamic acid (SAHA) can increase(More)
  • 1